Association of chronic anticoagulant and antiplatelet use on disease severity in SARS-COV-2 infected patients

Saved in:
Bibliographic Details
Published inJournal of thrombosis and thrombolysis Vol. 52; no. 2; pp. 476 - 481
Main Authors Ho, Gwendolyn, Dusendang, Jennifer R., Schmittdiel, Julie, Kavecansky, Juraj, Tavakoli, Jahan, Pai, Ashok
Format Journal Article
LanguageEnglish
Published New York Springer US 01.08.2021
Springer Nature B.V
Subjects
Adolescent
Adult
Aged
Aged, 80 and over
Anticoagulants
Anticoagulants - adverse effects
Anticoagulants - therapeutic use
California - epidemiology
Cardiology
Comorbidity
COVID-19 - diagnosis
COVID-19 - mortality
COVID-19 - therapy
Female
Hematology
Hospitalization
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Mortality
Platelet Aggregation Inhibitors - adverse effects
Platelet Aggregation Inhibitors - therapeutic use
Respiration, Artificial
Retrospective Studies
Risk Assessment
Risk Factors
Severe acute respiratory syndrome coronavirus 2
Severity of Illness Index
Thromboembolism
Venous Thromboembolism - epidemiology
Ventilators
Young Adult
California
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0929-5305
1573-742X
DOI:10.1007/s11239-021-02383-w